Drug Design and Discovery in Alzheimer’s Disease - Softcover

9780128039595: Drug Design and Discovery in Alzheimer’s Disease
View all copies of this ISBN edition:
 
 

Drug Design and Discovery in Alzheimer’s Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an overview of AD pharmacotherapy and existing blockbuster drugs, the reviews cover the potential of both natural and synthetic small molecules; the role of cholinesterases in the on-set and progression of AD and their inhibition; the role of beta-site APP clearing enzyme-1 (BACE-1) in the production of ß-amyloid proteins, one of the key reasons of the progression of AD; and other targets identified for AD drug discovery.

  • Edited and written by leading experts in Alzheimer’s disease (AD) and other neurodegenerative disease drug development
  • Describes existing drugs for AD and current molecular understanding of the condition
  • Reviews recent advances in the field, including coverage of cholinesterases, BACE-1, and other drug development targets

"synopsis" may belong to another edition of this title.

About the Author:
Atta-ur-Rahman, Professor Emeritus, International Center for Chemical and Biological Sciences (H. E. J. Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicine and Drug Research), University of Karachi, Pakistan, was the Pakistan Federal Minister for Science and Technology (2000-2002), Federal Minister of Education (2002), and Chairman of the Higher Education Commission with the status of a Federal Minister from 2002-2008. He is a Fellow of the Royal Society of London (FRS) and an UNESCO Science Laureate. He is a leading scientist with more than 930 publications in several fields of organic chemistry.

Muhammad Choudhary, PhD, is a Professor of the International Center for Chemical and Biological Sciences, (H. E. J. Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicine and Drug Research), University of Karachi, Pakistan. He is a member of the Royal Society of Chemistry, London; American Chemical Society; International Union of Pure and Applied Chemistry (IUPAC); American Society of Pharmacology; New York Academy of Sciences; Federation of Asian Chemical Societies (FACS); and he serves on the executive board of the Asian Network of Research on Anti Diabetic Plants (ANRAP). He is a recipient of the National Book Foundation's Prize for Chemistry and the Economic Cooperation Organization (ECO) Award in Education, 2006, given by the President of Azerbaijan. He has published 24 books, more than 570 papers, and 20 patents.
Review:

"... comprehensive compilation of the current knowledge about Alzheimer's disease...recommended to anyone who will be working intensively on the subject..." (translated from German) --MTA Dialog

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

Stock Image

Published by Lala Maurizio (2015)
ISBN 10: 0128039590 ISBN 13: 9780128039595
New Softcover Quantity: > 20
Print on Demand
Seller:
Brook Bookstore On Demand
(Napoli, NA, Italy)

Book Description Condition: new. Questo è un articolo print on demand. Seller Inventory # c714aeaee1592c0a661a6812fe6c46db

More information about this seller | Contact seller

Buy New
US$ 100.77
Convert currency

Add to Basket

Shipping: US$ 11.91
From Italy to U.S.A.
Destination, rates & speeds
Seller Image

Atta-Ur Rahman
Published by ELSEVIER Jun 2015 (2015)
ISBN 10: 0128039590 ISBN 13: 9780128039595
New Taschenbuch Quantity: 2
Print on Demand
Seller:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Germany)

Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Drug Design and Discovery in Alzheimer's Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an overview of AD pharmacotherapy and existing blockbuster drugs, the reviews cover the potential of both natural and synthetic small molecules; the role of cholinesterases in the on-set and progression of AD and their inhibition; the role of beta-site APP clearing enzyme-1 (BACE-1) in the production of ß-amyloid proteins, one of the key reasons of the progression of AD; and other targets identified for AD drug discovery. 784 pp. Englisch. Seller Inventory # 9780128039595

More information about this seller | Contact seller

Buy New
US$ 102.44
Convert currency

Add to Basket

Shipping: US$ 24.61
From Germany to U.S.A.
Destination, rates & speeds
Stock Image

Atta-ur-Rahman
ISBN 10: 0128039590 ISBN 13: 9780128039595
New Paperback Quantity: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)

Book Description Paperback. Condition: Brand New. 1st edition. 784 pages. 9.00x7.50x1.25 inches. In Stock. Seller Inventory # __0128039590

More information about this seller | Contact seller

Buy New
US$ 116.78
Convert currency

Add to Basket

Shipping: US$ 12.46
From United Kingdom to U.S.A.
Destination, rates & speeds
Seller Image

Atta-Ur Rahman
Published by Elsevier Health Sciences (2015)
ISBN 10: 0128039590 ISBN 13: 9780128039595
New Taschenbuch Quantity: 2
Print on Demand
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)

Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Drug Design and Discovery in Alzheimer's Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an overview of AD pharmacotherapy and existing blockbuster drugs, the reviews cover the potential of both natural and synthetic small molecules; the role of cholinesterases in the on-set and progression of AD and their inhibition; the role of beta-site APP clearing enzyme-1 (BACE-1) in the production of ß-amyloid proteins, one of the key reasons of the progression of AD; and other targets identified for AD drug discovery. Seller Inventory # 9780128039595

More information about this seller | Contact seller

Buy New
US$ 114.71
Convert currency

Add to Basket

Shipping: US$ 35.30
From Germany to U.S.A.
Destination, rates & speeds
Seller Image

Rahman, Atta-Ur
ISBN 10: 0128039590 ISBN 13: 9780128039595
New Softcover Quantity: > 20
Print on Demand
Seller:
moluna
(Greven, Germany)

Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Drug Design and Discovery in Alzheimer s Disease includes expert reviews of recent developments in Alzheimer s disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volum. Seller Inventory # 35220890

More information about this seller | Contact seller

Buy New
US$ 98.91
Convert currency

Add to Basket

Shipping: US$ 52.42
From Germany to U.S.A.
Destination, rates & speeds